Review

Recent advancements in the targeted therapy of metastatic kidney cancer
  • Sertaç Yazıcı
  • Halil Kızılöz
  • Haluk Özen
Bull Urooncol 2011; 10: 41-51
New chemotherapeutic approaches in testicular tumors
  • Arzu Yaren
  • Gamze Gököz Doğu
  • Serkan Değirmencioğlu
Bull Urooncol 2011; 10: 75-81
Adjuvant and Neoadjuvant Targeted Therapies in Locally Advanced Renal Cell Carcinoma
  • Ozan Bozkurt
  • Ömer Demir
Bull Urooncol 2014; 13: 139-145 DOI: 10.4274/uob.82
Most frequently seen side effects of targeted therapy: how to manage?
  • Önder Kara
  • Bülent Akdoğan
Bull Urooncol 2013; 12: 179-185
Neoadjuvant targeted therapy in renal cell carcinoma
  • Sertaç Yazıcı
  • Halil Kızılöz
  • Haluk Özen
Bull Urooncol 2012; 11: 240-245
Diagnostic and Prognostic Molecular Features of Urothelial Bladder Cancer and New Treatment Approaches
  • Zafer Küçükodacı
  • Kutsal Yörükoğlu
Bull Urooncol 2015; 14: 258-270 DOI: 10.4274/uob.366
Quality of Life of Patients with Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period with Targeted Drugs
  • Sinharib Çitgez
Bull Urooncol 2015; 14: 321-323 DOI: 10.4274/uob.460

Article - Comment

Surgical resection of renal cell carcinoma after targeted therapy
  • Asıf Yıldırım
Bull Urooncol 2009; 8: 77-81

Review

Contemporary Trends in Adjuvant and Neoadjuvant Treatment for Renal Cell Carcinoma
  • Kamil Çam
Bull Urooncol 2018; 17: 98-104 DOI: 10.4274/uob.1030

General Urooncology

An approach to dermatological side effects of targeted therapies
  • Cemal Bilaç
  • Sedef Bayata
  • Serap Öztürkcan
Bull Urooncol 2012; 11: 295-300

About Journal

Forms

Useful Links

Applications